Mechanism of action
Chloroform produces general anesthesia through multiple mechanisms affecting the central nervous system:
- GABA_A receptor potentiation: Enhances inhibitory neurotransmission by increasing chloride channel opening frequency and duration, leading to neuronal hyperpolarization
- NMDA receptor antagonism: Blocks excitatory glutamatergic transmission
- Potassium channel modulation: Activates background potassium channels, contributing to membrane hyperpolarization
- Lipid membrane perturbation: Disrupts neuronal membrane function through direct physicochemical effects
The net effect is dose-dependent CNS depression progressing from anxiolysis to unconsciousness and surgical anesthesia. Chloroform also depresses myocardial contractility and sensitizes the heart to catecholamines, predisposing to ventricular arrhythmias.
- Chloroform produces general anesthesia by potentiating GABA_A receptors and is metabolized by CYP2E1 to toxic phosgene
- Hepatotoxicity manifests as centrilobular necrosis 24-72 hours post-exposure due to phosgene formation
- Chloroform sensitizes the myocardium to catecholamines, causing fatal ventricular arrhythmias—the most common cause of anesthetic death
- Alcohol (ethanol) dramatically increases chloroform hepatotoxicity by inducing CYP2E1 enzyme
- Chloroform is a Group 2B carcinogen (possibly carcinogenic to humans) associated with hepatic and renal tumors
- No longer used clinically due to narrow therapeutic index and availability of safer volatile anesthetics like sevoflurane
- N-acetylcysteine is recommended as an antidote to replenish glutathione stores and mitigate phosgene-mediated hepatotoxicity
- Classic toxicology triad: CNS depression, delayed hepatic necrosis, and sudden cardiac death
Indications
Chloroform has no current therapeutic indications and is not used in modern clinical practice. Historical uses included:
- General anesthesia for surgical procedures (discontinued in most countries by the 1970s)
- Obstetric analgesia (famously used by Queen Victoria during childbirth)
- Topical analgesic in liniments (obsolete)
Chloroform is now used only as an industrial solvent and laboratory reagent. Its use in medicine was abandoned due to:
- Narrow therapeutic index
- Severe hepatotoxicity
- Cardiac toxicity and sudden death
- Availability of safer volatile anesthetics (halothane, isoflurane, sevoflurane)
Any discussion of chloroform in modern medicine is in the context of toxicology and historical perspective.
Pharmacokinetics
Absorption and distribution
Chloroform is rapidly absorbed through the lungs when inhaled and distributes widely throughout body tissues due to high lipid solubility. It crosses the blood-brain barrier and placenta readily. Peak brain concentrations occur within minutes of inhalation.
Metabolism
Chloroform undergoes extensive hepatic metabolism via cytochrome P450 enzymes, particularly CYP2E1:
- Oxidative metabolism produces phosgene (COCl₂), a highly reactive and toxic intermediate
- Phosgene binds covalently to cellular macromolecules, causing hepatocellular necrosis
- Further metabolism yields carbon dioxide, chloride ions, and hydrochloric acid
- Reductive metabolism generates dichloromethyl radical, contributing to lipid peroxidation
Elimination
Chloroform is eliminated through multiple routes:
- Pulmonary excretion: Unchanged chloroform is exhaled (major route)
- Renal excretion: Metabolites eliminated in urine
- Half-life: Approximately 8 hours, but tissue accumulation occurs with repeated exposure
Factor influencing toxicity include CYP2E1 inducers (alcohol, isoniazid) which increase toxic metabolite formation.
Adverse effects
Chloroform toxicity affects multiple organ systems and can be life-threatening:
Hepatotoxicity
- Centrilobular hepatic necrosis: Most serious adverse effect, occurs 1-3 days post-exposure
- Elevated transaminases (AST, ALT), jaundice, coagulopathy
- Can progress to acute hepatic failure
- Mechanism: phosgene-mediated covalent binding and oxidative stress
Cardiac toxicity
- Ventricular arrhythmias: Sudden cardiac death, the most common cause of anesthetic mortality with chloroform
- Myocardial sensitization to catecholamines (endogenous and exogenous)
- Direct myocardial depression, hypotension
- QT prolongation and torsades de pointes
Nephrotoxicity
- Acute tubular necrosis
- Oliguria, proteinuria, hematuria
- Mechanism: toxic metabolite accumulation and direct tubular injury
Respiratory depression
- Dose-dependent CNS depression
- Respiratory arrest at high concentrations
- Loss of protective airway reflexes
Carcinogenicity
- IARC Group 2B carcinogen (possibly carcinogenic to humans)
- Associated with hepatocellular carcinoma and renal tumors in animal studies
Other effects
- Nausea, vomiting (common)
- CNS effects: dizziness, headache, confusion
- Dermal contact: irritation, chemical burns
- Chronic exposure: neuropsychiatric symptoms, liver and kidney damage
Contraindications and warnings
Absolute contraindications
Chloroform is contraindicated for all clinical uses due to unacceptable toxicity. If discussing historical contraindications:
- Known hypersensitivity
- Severe hepatic impairment
- Severe cardiac disease, arrhythmias
- Porphyria (can precipitate acute attacks)
Black box equivalent warnings
If chloroform were still used, it would carry warnings for:
- Hepatotoxicity: Risk of fatal hepatic necrosis
- Cardiac arrest: Sudden death from ventricular arrhythmias
- Carcinogenicity: Long-term cancer risk
Special populations
Pregnancy: Chloroform crosses the placenta and causes fetal CNS depression. Historical use was associated with maternal and fetal complications. Modern classification would be Category D or X.
Lactation: Excreted in breast milk; toxic to nursing infant.
Pediatric: Children are more susceptible to CNS and respiratory depression.
Geriatric: Increased sensitivity to CNS effects; higher risk of cardiac complications.
Occupational exposure
Laboratory workers and industrial settings require:
- Adequate ventilation and fume hoods
- Personal protective equipment
- Monitoring for signs of acute or chronic toxicity
Drug interactions
Although chloroform is not used clinically, understanding its interactions is relevant for toxicology:
CYP2E1 inducers
- Alcohol (ethanol): Significantly increases chloroform hepatotoxicity by inducing CYP2E1 and enhancing phosgene formation
- Isoniazid: Increases toxic metabolite production
- Chronic ethanol exposure is a major risk factor for chloroform-induced liver injury
Sympathomimetics
- Epinephrine, norepinephrine: Markedly increase risk of ventricular arrhythmias due to myocardial sensitization
- Historical anesthetic deaths often occurred when epinephrine was used for hemostasis during chloroform anesthesia
Other CNS depressants
- Opioids, benzodiazepines, barbiturates, alcohol: Additive CNS and respiratory depression
- Increased risk of respiratory arrest
Hepatotoxic agents
- Acetaminophen, carbon tetrachloride, other halogenated hydrocarbons: Additive hepatotoxicity
Nephrotoxic agents
- Aminoglycosides, NSAIDs: Additive renal injury
No drugs should be used to "manage" chloroform anesthesia in modern practice. Treatment of chloroform toxicity is supportive.
Clinical pearls
- Historical significance: Chloroform was one of the first general anesthetics (introduced 1847), but its narrow therapeutic index led to its abandonment. It exemplifies why safety profiles are as important as efficacy.
- Mechanism of hepatotoxicity: The formation of phosgene (a chemical warfare agent) via CYP2E1 explains the delayed hepatic necrosis seen 24-72 hours after exposure. This is a classic example of metabolic activation to a toxic intermediate.
- Cardiac sensitization: Chloroform is the prototype drug for catecholamine-induced arrhythmias. This mechanism is shared by other halogenated hydrocarbons and is clinically relevant for understanding volatile anesthetic cardiac effects.
- Exam association: Questions often present chloroform in historical vignettes or toxicology scenarios. Key buzzwords are "sweet-smelling solvent," "centrilobular necrosis," "sudden cardiac death during anesthesia," and "CYP2E1 metabolism."
- Differential diagnosis: In a patient with unexplained hepatic necrosis and history of solvent exposure, consider chloroform alongside carbon tetrachloride and other halogenated hydrocarbons.
- Antidote and treatment: Treatment of chloroform toxicity is primarily supportive—airway management, hemodynamic support, avoiding catecholamines if possible, and monitoring liver and kidney function. N-acetylcysteine is recommended as an adjunct to replenish glutathione stores depleted by the toxic phosgene metabolite, thereby mitigating hepatotoxicity.
- Modern relevance: While not used medically, chloroform remains a laboratory reagent and industrial solvent. Accidental or intentional exposures still occur, making toxicology knowledge clinically relevant.
- Comparison to modern anesthetics: Safer volatile anesthetics (sevoflurane, desflurane) have much wider therapeutic indices, minimal metabolism, and lack the hepatotoxic and cardiotoxic profile of chloroform.
Practice questions
1. A 45-year-old laboratory technician is brought to the emergency department after being found unconscious near a chemical spill. Coworkers report he was working with organic solvents. On arrival, he is obtunded with shallow respirations at 8/min, blood pressure 85/50 mmHg, and heart rate 115/min with frequent premature ventricular contractions on monitor. He has a fruity, sweet odor on his breath. Initial liver function tests are normal, but 48 hours later AST rises to 3,500 U/L and ALT to 3,200 U/L with elevated INR. Which toxic mechanism best explains the delayed hepatotoxicity?
2. A medical historian presents a case from 1890 in which a 32-year-old woman died suddenly during appendectomy while under chloroform anesthesia. The surgeon had just injected dilute epinephrine solution for hemostasis when the patient developed ventricular fibrillation and could not be resuscitated. Autopsy showed no structural heart disease. Which property of chloroform best explains this fatal outcome?
3. A 28-year-old chronic alcoholic presents to the emergency department with nausea, vomiting, and right upper quadrant pain 36 hours after recreational inhalation of chloroform. Laboratory studies show AST 4,200 U/L, ALT 3,800 U/L, total bilirubin 3.2 mg/dL, and INR 2.8. Which factor most significantly increased this patient's risk of hepatotoxicity?
Frequently asked questions
How does chloroform work as an anesthetic?
Chloroform produces general anesthesia primarily by enhancing GABA_A receptor activity, which increases inhibitory neurotransmission in the central nervous system. It also blocks NMDA receptors and modulates potassium channels, leading to neuronal hyperpolarization and dose-dependent CNS depression. These mechanisms result in unconsciousness and loss of sensation required for surgical anesthesia. However, chloroform is no longer used clinically due to severe toxicity including hepatotoxicity and fatal cardiac arrhythmias.
What are the side effects of chloroform?
The most serious side effects of chloroform are hepatotoxicity (centrilobular hepatic necrosis occurring 1-3 days after exposure) and cardiac toxicity (ventricular arrhythmias and sudden death from myocardial sensitization to catecholamines). Other adverse effects include nephrotoxicity with acute tubular necrosis, respiratory depression, nausea, vomiting, and CNS effects like dizziness and confusion. Chronic exposure can cause neuropsychiatric symptoms and progressive liver and kidney damage. Chloroform is also classified as a possible human carcinogen associated with hepatic and renal tumors.
Why is chloroform no longer used in medicine?
Chloroform was discontinued from medical use due to its unacceptably narrow therapeutic index and severe toxicity profile. The primary reasons include frequent fatal cardiac arrhythmias (sudden death during anesthesia), delayed hepatotoxicity causing acute liver failure, nephrotoxicity, and carcinogenic potential. The development of safer volatile anesthetics like halothane, isoflurane, and sevoflurane—which have wider safety margins and less organ toxicity—made chloroform obsolete. Its metabolism produces phosgene, a highly toxic intermediate that causes cellular damage, making it particularly dangerous.
Is chloroform a controlled substance?
Chloroform is not a controlled substance under the US Controlled Substances Act, as it has no accepted medical use and is not used recreationally in the manner of scheduled drugs. However, it is regulated as a hazardous chemical by OSHA and EPA due to its toxicity and carcinogenic potential. Large-quantity purchases may be monitored because chloroform has been used in criminal activities. In laboratory and industrial settings, its use is strictly controlled through safety regulations requiring proper ventilation, personal protective equipment, and exposure monitoring.
Chloroform vs halothane—what is the difference?
Both chloroform and halothane are halogenated hydrocarbon anesthetics, but halothane has a significantly better safety profile. Chloroform causes frequent fatal cardiac arrhythmias through marked catecholamine sensitization and produces severe hepatotoxicity via phosgene formation through CYP2E1 metabolism. Halothane, while also hepatotoxic in rare cases (halothane hepatitis), has a wider therapeutic index and causes arrhythmias less frequently. Halothane largely replaced chloroform in the mid-20th century but has itself been superseded by even safer agents like sevoflurane and desflurane.
Related drugs
Sources and further reading
DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: N01AB02
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.